New Biotech, Synaptix, launched to develop treatment for Tubb4a H-abc!
Very exciting news for the H-abc community. Biotech Synaptix has launched and are working hard to develop ASO gene therapy for H-abc and Tubb4a. Click on their website below to learn more.
The pitch here centers on combining premium publishers with high-value advertisers, which is a common but tricky balance to get right. The JZZ Media platform seems built around that pairing, so it may be worth a look for regional campaign planning.